References

1. Bird AC, Bressler NM, Bressler SB et al. An International Classification and Grading System for Age-Related Maculopathy and Age-Related Macular Degeneration. The International ARM Epidemiology Study Group. Surv Ophthalmol. 1995; 39: 367-374.

2. Buch H, Vinding T, Nielsen NV et al. 14-year incidence progression and visual morbidity of age-related maculopaty: The Copenhagen City Eye Study. Ophthalmology. 2005; 112:787-798.

3. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration: Age-Related Eye Disease Study (AREDS) report nº 17. Arch Ophthalmol. 2005; 123: 1484-1498.

4. Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in Age-Related Eye disease Study: AREDS report nº 8. Arch Ophthalmol. 2008; 119:1417-1436.

5. Gass JDM. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol.1973; 90:206-217.

6. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984; 102:1640-1642.

7. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology.1992; 99:933-943.

8. Vingerling JR, Dielmans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology.1995;102:205-210.

9. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountais Eye Study . Ophthalmology.1995; 102:1450-1460.

10. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology. 2001; 108:697-704.

11. Fraser-Bell S, Wu J, Klein R, et al. Smoking, Alcohol Intake, Estrogen Use, and Age-related Macular Degeneration in Latinos: The Los Angeles Latino Eye Study. Am J Ophthalmology. 2006; 141: 79-87.

12. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: A case-control study in the Age-Related Eye Disease Study: AREDS report nº3. Ophthalmolgy.2000; 107:2224-2232.

13. Age-Related Eye Disease Study Research Group. Risk factors for the incidence of Advanced Age-Related Macular Degeneration in Age-Related Eye Disease Study: AREDS report nº 19. Ophthalmology.2005; 112:533-539.

14. Friedman DS, Katz J, Bressler NM, et al. Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology.1999; 106:1049-1055.

15. Klein R, Klein BE, Knudtson M, et al. Pevalence of Age-related Macular Degeneration in 4 Racial/Ethnic Groups in the Multi-ethnic Study of Atherosclerosis. Ophthalmology.2006; 113:373-380.

16. Klein R, Klein BE, Tomany SC. The Association of Cardiovascular Disease with the Long-term Incidence of Age-Related Maculopathy: The Beaver Dam Eye Study. Ophthalmology. 2002; 110:1273-1280.

17. Tan JS, Mitchell P, Smith W, Wang JJ, et al. Cardiovascular Risk Factors and the Long-term Incidence of Age-Related Macular Degeneration: The Blue Mountais Eye Study. Ophthalmology. 2009; 114:1143-1149.

18. Postel EA, Agarwal A, Caldwell J, et al. Complement Factor H Increases Risk for Atrophic Age-Related Macular Degeneration. Ophthalmology. 2006; 113:1504-1507.

19. Dominiek DG, Cornelia MD, Oostra BA, et al. Complement Component C3 and Risk of Age-Related Macular Degeneration. Ophthalmology. 2009; 115:474-480.

20. Cameron DJ, Yang Z, et al. HTRA1 variant confer similar risk to Geographic Atrophy and Neovascular Age-Related Macular Degeneration. Cell Cycle 2007; 6:9, 1122-1125.

21. MajewskiJ, Schultz DW, Weleber RG, et al. Age-Related Macular Degeneration: a genome scan in extended families. Am J Hum Genet. 2003; 73: 540-550.

22. Abecasis GR, Yashar BM, Zhao Y, et al. Age-related macular degeneration : a high resolution genome scan for susceptibility loci in a population enriched for late-stage disease. Am J Hum Genet. 2004; 74:482-494.

23. Klein ML, Ferris FLIII, Armstrong J, et al. (AREDS Research Group). Retinal Precursors and the Development of Geographic Atrophy in Age-Related Macular Degeneration. Ophthalmolgy. 2008; 115:1026-1031.

24. Pauleikhoff D, Spital G, Bird AC. A Fluorescein and Indocyanine Green Angiographic Study of Choriocapillaris in Age-related Macular Disease. Arch Ophthalmol. 1999; 117:1353-1358.

25. Age-Related Eye Disease Study Research Group. Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: AREDS report nº 28. Ophthalmology.2010; 117:489-499.

26. Casswell AG Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol. 1985; 69:397-403.

27. Sparrow JR, Boulton M. Lipofuscin and its role in retinal pathobiology. Exp Eye Res.2005; 80:595-606.

28. Sarks JP, Sarks SH, Killingsworth M. Evolution of geographic atrophy of the retinal pigment epithelium. EYE. 1988; 2:552-577.

29. Lutty G, Grunwald J, Majji AB,et al. Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration. Mol Vis. 1999;5:35. PUBMED.

30. McLeod DS, Taomoto M, Otsuji T, et al. Quantifying Changes in RPE and Choroidal Vasculature in Eyes with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2002; 43:1986-1993.

31. Curcio CA, Medeiros NE, Milican CL. Photoreceptor Loss in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 1996; 37:1236-1249.

32. Kim SY, Sadda S, Humayun MS, et al. Morphometric Analysis of the Macula in Eyes With Geographic Atrophy due to Age-Related Macular Degeneration. Retina. 2002; 22:464-470.

33. Holz FG, Schutt F, Kopitz J, et al. Inhibition of Lysosomal Degradative Functions in RPE Cells by a Retinoid Component of Lipofuscin. Invest Ophthalmol Vis Sci. 1999; 40:737-743.

34. Beatty S, Koh H, Phil M, et al. The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration. Surv Ophthalmol. 2000; 45:115-134.

35. Rózanowska M, Korytowski W, Rózanowski B, et al. Photoreactivity of Aged Human RPE Melanosomes: A Comparison with Lipofuscin. Invest Ophthalmol Vis Sci. 2002; 43:2088-2096.

36. Anderson DH, Mullins RF, Hageman GS, et al. A Role for Local Inflammation in the Formation of Drusen in the Aging Eye. Am J Ophthalmol. 2002; 134:411-431.

37. Coleman H R, Ferris III FL, Chew EY, et al. Age related macular degeneration. Lancet. 2008 ; 372 (9652):1835-1845.

38. Bischoff P, Speiser P. The role of angiography in age-related macular degeneration . Klin Monatsbl Augenheilkd. 1997; 210:196-8. Abstract.

39. Shuman JS, Puliafito CA, Fujimoto JG, et al. Optical Coherence Tomography of Ocular Diseases. Second edition. Slack, 2004.

40. Bearelly S, Chau FY, Koreishi A, et al. Spectral Domain Coherence Tomography Imaging of Geographic Atrophy Margins. Ophthalmology. 2009; 116:1762-1769.

41. Fleckenstein M, Issa PC, Holz FG, et al. High-Resolution Spectral Domain-OCT Imaging in Geographic Atrophy Associated with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2008; 49(9):4137-4144.

42. Delori FC, Dorey CK, Staurenghi G, et al. In Vivo Fluorescence of the Ocular Fundus Exhibits Retinal Pigment Epithelium Lipofuscin Characteristics. Invest Ophthalmol Vis Sci 1995;36:718-729.

43. Sparrow JR, Fishkin N, Zhou J, et al. A2E, a Byoproduct of the Visual Cycle. Vision Res. 2003; 43:2983-2990.

44. Frangieh GT, Green WR, Fine SL. A histopathological Study of Best’s Macular Dystrophy. Arch Ophthalmol. 1982; 100: 1115-1121.

45. Sparrow JR, Boulton M. Lipofuscin and its role in retinal pathobiology. Exp Eye Res. 2005; 80: 595-606.

46. Von Ruckmann A, Fitzke FW, Bird AC. Fundus Autofluorescence in Age-Related Macular Disease Imaged with Laser scanning Ophthalmoscope. Invest Ophthalmol Vis Sci. 1997; 38:478-86.

47. Holz FG, Bellman C, Staudt S, et al. Fundus Autofluorescence and Development of Geographic Atrophy in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2001; 42:1051-1056.

48. Schmitz-Valkenberg S, Bültmann S, Dreyhaupy J, et al. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004; 45:4470-4476.

49. Schmitz-Valckenberg S, Bindewald-Wittich A, Dolar-Szczasny J, et al. Fundus Autofluorescence and Fundus Perimetry in the Junctional Zone of Geographic Atrophy in Patients with Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2006; 47:2648-2654.

50. Hwang JC, Chan JWK, Smith T, et al. Predictive Value of Fundus Autofluorescence for Development of Geographic Atrophy in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2006;47: 2655-2661.

51. Suness JS, Gonzalez-Baron J, Bressler NM, et al. The Development of Choroidal Neovascularization in Eyes with Geographic Atrophy Form of Age-Related Macular Degeneration. Ophthalmology.1999; 106:910-919.

52. Suness JS, Applegate CA, Bressler NM, et al. Visual Function Abnormalities and Prognosis in Eyes with Age-Related Geographic Atrophy of the Macula and Good Visual Acuity. Ophthalmology.1997; 1677-1691.

53. Suness JS, Margalit E, Bressler NM, et al. The Long-term Natural History of Geographic Atrophy from Age-Related Macular Degeneration: Enlargement of Atrophy and Implications for Interventional Clinical Trials. Ophthalmology. 2007;114:271-277.

54. Bellmann C, Jorzik J, Spital G, et al. Symmetry of bilateral lesions in geographic atrophy in patients with age-related macular degeneration. Ophthalmology. 2002; 120: 579-584.

55. Suness JS, Rubin GS, Broman A, et al. Low luminance Visual Dysfunction as a Predictor of Subsequent Visual Loss From Geographic Atrophy in Age-Related Macular Degeneration. Ophthalmology. 2008; 115:1480-1488

56. Maguire P, Vine AK. Geographic Atrophy of Retinal Pigment Epithelium. Am J Ophthalmol.1986; 102: 621-625.

57. Suness JS, Gonzalez-Baron J, Applegate CA, et al. Enlargement of Atrophy and Visual Acuity Loss in the Geographic Atrophy Form of Age-Related Macular Degeneration. Ophthalmology. 1999; 106:1768-1779.

58. Schatz H, McDonald HR. Atrophic Macular Degeneration. Rate of Spread of Geographic Atrophy and Visual Loss. Ophthalmology. 1989; 96: 1541-1551.

59. Coleman H, Chew E. Nutritional Supplementation in Age-Related Macular Degeneration. Curr Opin Ophthalmol. 2007; 18: 220-223.

60. Age-Related Eye Disease Study Research Group. Risk Factors for the Incidence of Advanced Age-Related Macular Degeneration in Age-Related Eye Disease Study : AREDS report nº 23. Arch Ophthalmol.2008; 126: 1274-1279.

61. Chiu CJ, Milton RC, Klein R et al. Dietary Compound Score and Risk of Age-Related Macular Degeneration in the Age-Related Eye Disease Study. Ophthalmology.2008;116: 939-946.

62. Rosenfeld PJ, Legarreta J. Preclinical/ Phase I Dry AMD Rx Pipeline Review. AAO Subspeciality Day Retina Sillabus.2009; p80-84.

63. Tao W, Wen R, Goddard MB, et al. Encapsulated Cell-based Delivery of CNTF Reduces Photoreceptor Degeneration in Animal Models of Retinitis Pigmentosa. Invest Ophthalmol Vis Sci. 2002; 43:3292-3298.

64. Konstantin Petrukin. New Therapeutic Targets in Atrophic Age-Related Macular Degeneration. Expert Opin Ther Targets. 2007; 11: 625-639.

65. Tanito M, Li F, Elliot MH, et al. Protective effect of TEMPOL derivates against Light-Induced Retinal Damage in Rats. Invest Ophthalmol Vis Sci. 2007; 48:1900-1905.

66. Zhou J, Kim SR, Sparrow JR, et al. Complement Activation by Bisretinoid Constituents of RPE Lipofuscin. Invest Ophthalmol Vis Sci. 2009; 50:1392-1399.